Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US5866590 | CEPHALON | Pharmaceutical composition containing tiagabine hydrochloride and the process for its preparation |
Apr, 2016
(8 years ago) | |
US5958951 | CEPHALON | Modified form of the R(-)-N-(4,4-di(3-methylthien-2-yl)but-3-enyl)-nipecotic acid hydrochloride |
Jun, 2017
(6 years ago) |
Market Authorisation Date: 16 April, 1999
Treatment: NA
Dosage: TABLET;ORAL